Home › NDC Lookup › Ingredients › Valsartan And Hydrochlorothiazide › 70771-1489-00
valsartan and hydrochlorothiazide 320 mg; 25 mg Tablet, Film Coated, 1,000-count — NDC 70771-1489-00 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

valsartan and hydrochlorothiazide 320 mg; 25 mg Tablet, Film Coated, 1,000-count — NDC 70771-1489-0 (Billing 70771-1489-00)

by Zydus Lifesciences Limited · 1000 TABLET, FILM COATED in 1 BOTTLE

This is a package of 1,000 tablets of valsartan and hydrochlorothiazide 320 mg; 25 mg Tablet, Film Coated from Zydus Lifesciences Limited, marketed since Feb 2020 and currently FDA-listed. It is the main listing for this product, which comes in 3 package sizes.

NDC 70771-1489-00
🏷️ FDA NDC (as labeled) 70771-1489-0 billing pads the package segment with a zero
This package
Contains1,000-count Pack sizes3 compare ↓
Also priced by: Part D plans $0.3156/unit — full pricing hub ↓
Main listing for product 70771-1489 · Also comes in: 10 tablets 70771-1489-4 90 tablets 70771-1489-9
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70771-1489-0
Product NDC 70771-1489
11-digit billing NDC 70771148900
RxCUI 200284, 200285, 349353, 636042, 636045
UNII 0J48LPH2TH, 80M03YXJ7I
UPC 0370771148905
Application # ANDA203000
SPL Set ID bd199010-1d85-4011-939c-4704ecfaba1f
Established class (EPC) Thiazide Diuretic; Angiotensin 2 Receptor Blocker
Mechanism of action Angiotensin 2 Receptor Antagonists
Physiologic effect Increased Diuresis
Chemical class Thiazides
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-02-12
Route ORAL
Dosage form TABLET, FILM COATED
Substance VALSARTAN; HYDROCHLOROTHIAZIDE
Quick answers
  • RxCUI (RxNorm): 200284
Why two NDCs? The FDA registers this code as 70771-1489-0 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70771-1489-00. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Thiazide Diuretic class.

Pharmacologic class Thiazide Diuretic
Drug family (ATC) Renin-inhibitors, Thiazides, plain
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 What it is MedlinePlus · NLM

Hydrochlorothiazide is used alone or in combination with other medications to treat high blood pressure. Hydrochlorothiazide is used to treat edema (fluid retention; excess fluid held in body tissues) caused by various medical problems, including heart, kidney, and liver disease and to treat edema caused by using certain medications including estrogen and corticosteroids. Hydrochlorothiazide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine. High blood pressure is a common condition...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • This tablet combines two different blood pressure-lowering medicines in one pill: valsartan, which relaxes your blood vessels, and hydrochlorothiazide, a water pill that helps your...
  • What exactly is this medication and why did my doctor prescribe it?
  • You can take it either way — with or without food. The hydrochlorothiazide part isn't affected by food at all. Food does reduce how much valsartan your body absorbs, but since you...
  • Does it matter if I take it with food or on an empty stomach?
📖 Read our full Valsartan and Hydrochlorothiazide guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.3156 $315.60 / 1000 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70771-1489-00 You're viewing this Main listing 1000 TABLET, FILM COATED in 1 BOTTLE 2020-02-12 — Active
70771-1489-04 70771-1489-4 10 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK 2020-02-12 — Active
70771-1489-09 70771-1489-9 90 TABLET, FILM COATED in 1 BOTTLE 2020-02-12 — Active

Pack size FAQ

What quantity is in this package?
This is a 1,000-count package — 1000 tablet, film coated in 1 bottle.
How does this package differ from NDC 70771-1489-09?
Both are valsartan and hydrochlorothiazide 320 mg; 25 mg Tablet, Film Coated — the drug itself is identical. This page's package is the 1,000-count one, while NDC 70771-1489-09 is the 90 tablets package.
What NDC number is used to bill for this package of valsartan and hydrochlorothiazide 320 mg; 25 mg Tablet, Film Coated?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 00378-6325-77 Mylan 90 tablets $0.192 AB Availability likely —
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 33342-0078-10 Macleods 90 tablets $0.192 AB Availability likely —
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 65862-0551-05 Aurobindo 500 tablets $0.192 — Availability likely —
Diovan HCT 320 mg/1; 25 mg 00078-0472-34 Novartis 90 tablets $16.380 AB Availability likely —
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 42291-0969-90 AvKARE 90 tablets — AB FDA listed —
Valsartan And Hydrochlorothiazide 320 mg/1; 25 mg 43547-0315-03 Solco 30 tablets — AB FDA listed —
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 46708-0457-10 Alembic 100 tablets — AB FDA listed —
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 50090-5345-00 A-S 90 tablets — AB FDA listed —
Valsartan And Hydrochlorothiazide 320 mg/1; 25 mg 50090-7443-00 A-S 90 tablets — AB FDA listed —
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 51655-0243-52 Northwind 30 tablets — AB FDA listed —
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 51655-0655-52 Northwind 30 tablets — AB FDA listed —
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 53746-0849-90 Amneal 90 tablets — AB FDA listed —
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 62332-0083-10 Alembic 100 tablets — AB FDA listed —
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 63187-0694-30 Proficient 30 tablets — AB FDA listed —
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 65162-0849-03 Amneal 30 tablets — AB FDA listed —
valsartan and hydrochlorothiazide 320 mg/1; 25 mgthis 70771-1489-00 Zydus 1000 tablets — — FDA listed —
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 71205-0015-30 Proficient 30 tablets — AB FDA listed —
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 71335-0547-01 Bryant 30 tablets — AB Discontinued —
Valsartan and Hydrochlorothiazide 320 mg/1; 25 mg 71335-0853-01 Bryant 30 tablets — AB FDA listed —
Valsartan And Hydrochlorothiazide 320 mg/1; 25 mg 71335-2200-01 Bryant 30 tablets — AB FDA listed —
Valsartan And Hydrochlorothiazide 320 mg/1; 25 mg 50228-0151-05 ScieGen 500 tablets — AB FDA listed —
Valsartan And Hydrochlorothiazide 320 mg/1; 25 mg 84677-0076-90 Golden 90 tablets — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Feb 2020
📍
2026
Currently FDA-listed
6 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color Pink / Brown
ShapeOval
Imprint283
Size21 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII L11K75P92J
    A mineral salt made from calcium and phosphate. It acts as a filler and binder in tablets to add bulk and help hold the medicine together in solid form.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 2S7830E561
    Crospovidone is a synthetic polymer derived from povidone. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the active ingredient can be absorbed.
  • UNII 1K09F3G675
    Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
  • UNII EX438O2MRT
    Ferric oxide yellow is a naturally occurring iron compound used as a colorant in medications. It gives tablets, capsules, and other forms a yellow or golden hue for identification and appearance.
  • UNII XM0M87F357
    A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 4R4HFI6D95
    Polyethylene glycol 4000 is a synthetic polymer derived from petroleum. It serves as a binder, filler, and lubricant in solid dosage forms, and helps control how quickly the medicine dissolves.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

12 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerZydus Lifesciences Limited
Application holderZYDUS LIFESCIENCES LTD
FDA applicationANDA203000 (ANDA)
Labeler code70771
First marketedFeb 2020
Product typeHuman Prescription Drug
Portfolio720 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 Package Label / Principal Display Panel
📄 Package Label / Principal Display Panel 114 words ▾

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Valsartan and Hydrochlorothiazide Tablets USP, 80/12.5 mg NDC 70771-1485-0 in bottle of 1000 tablets 1000 tablets Rx only Valsartan and Hydrochlorothiazide Tablets USP, 160/12.5 mg NDC 70771-1486-0 in bottle of 1000 tablets 1000 tablets Rx only Valsartan and Hydrochlorothiazide Tablets USP, 160/25 mg NDC 70771-1487-0 in bottle of 1000 tablets 1000 tablets Rx only Valsartan and Hydrochlorothiazide Tablets USP, 320/12.5 mg NDC 70771-1488-0 in bottle of 1000 tablets 1000 tablets Rx only Valsartan and Hydrochlorothiazide Tablets USP, 320/25 mg NDC 70771-1489-0 in bottle of 1000 tablets 1000 tablets Rx only 80 mg/ 12.5 mg 160 mg/ 12.5 mg 160 mg/ 25 mg 320 mg/ 12.5 mg 320 mg/ 25 mg

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Zydus Lifesciences Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 10 tablets (70771-1489-04), 90 tablets (70771-1489-09). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Zydus Lifesciences Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 70771-1488-00 · Zydus 70771-1491-01 · Zydus →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.